Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related

Mechanisms of Tamoxifen Resistance: Increased Estrogen Receptor-HER2/neu Cross-Talk in ER/HER2-Positive Breast Cancer

2004 • 1,134 citations

Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial

2001 • 1,075 citations

Prognostic Factors in Breast Cancer

2000 • 1,068 citations

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

2000 • 1,034 citations

Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer

2003 • 767 citations

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

2003 • 716 citations

The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy

2003 • 604 citations

Quantitative Association Between HER-2/neu and Steroid Hormone Receptors in Hormone Receptor-Positive Primary Breast Cancer

2003 • 584 citations

Predicting Response to Endocrine Therapy in Human Breast Cancer: A Hypothesis

1975 • 570 citations

HER-2 Testing in Breast Cancer Using Parallel Tissue-Based Methods

2004 • 446 citations

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

1992 • 415 citations

Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.

1984 • 385 citations

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.

1992 • 360 citations

When Is a Tumor Marker Ready for Prime Time? A Case Study of c-erbB-2 as a Predictive Factor in Breast Cancer

2001 • 302 citations

Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study

2004 • 283 citations

Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening

2000 • 180 citations

Tumor-Specific Low Molecular Weight Forms of Cyclin E Induce Genomic Instability and Resistance to p21, p27, and Antiestrogens in Breast Cancer

2004 • 153 citations

HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer.

1989 • 150 citations

Tumor Variants by Hormone Receptor Expression in White Patients With Node-Negative Breast Cancer From the Surveillance, Epidemiology, and End Results Database

2001 • 138 citations

HER-2/neu Overexpression and Response to Oophorectomy Plus Tamoxifen Adjuvant Therapy in Estrogen Receptor-Positive Premenopausal Women With Operable Breast Cancer

2003 • 135 citations

Do we need HER‐2/neu testing for all patients with primary breast carcinoma?

2003 • 102 citations

Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor.

1992 • 100 citations

Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels

2000 • 97 citations

Upregulation of HER-2/neu by Ovarian Ablation: Results of a Randomized Trial Comparing Leuprorelin to CMF as Adjuvant Therapy in Node-positive Breast Cancer Patients

2003 • 8 citations